The Fontan procedure has revolutionized the treatment of univentricular hearts. However, it is associated with severe complications such as protein-losing enteropathy, plastic bronchitis, and peripheral edema that may involve the lymphatic circulation. We aimed to assess lymphatic function and morphology in patients with a univentricular circulation.
T
he Fontan circulation has revolutionized the treatment of the univentricular heart and allowed these children to reach adulthood. Although the Fontan circulation has revolutionized the outcome for patients born with a univentricular heart, this palliative surgical treatment causes an elevated central venous pressure (CVP) and impaired cardiac output-a physiological state that is over time thought to have detrimental effects on all organ systems. 1, 2 It is suggested that the elevated CVP can provoke manifestation of lymphatic dysfunction, seen as plastic bronchitis, peripheral edema, and protein-losing enteropathy, which can develop at any time. 3 The pathophysiology is complex and poorly understood. It seems a combination of increased CVP, altered mesenteric vascular resistance, inflammation, and lymphatic insufficiency is involved. [3] [4] [5] Characterization and further understanding of the lymphatic vasculature may guide the prevention and treatment of these devastating complications in Fontan patients. 6, 7 We hypothesize that an underlying lymphatic dysfunction could be a component of the Fontan complication profile. By determining how the lymphatic circulation of Fontan patients differs from healthy individuals, we may provide an important step toward understanding the role of the lymphatic vasculature in this patient group.
The lymphatic morphology has recently been characterized using noncontrast magnetic resonance imaging (MRI). [8] [9] [10] Dori et al 8, 11 used T2-weighted MRI to demonstrate lymphatic abnormalities in Fontan patients and guide during percutaneous interventional treatment procedures. 12 We have previously used near-infrared fluorescence (NIRF) imaging to study cutaneous lymphatic circulation in humans. 13, 14 Besides anatomy, NIRF imaging can describe function of the vessels because it allows realtime visualization of lymph flow. Strain gauge plethysmography in limbs is used to measure microvascular permeability. [15] [16] [17] [18] We aimed to investigate the anatomic lymphatic changes globally using noncontrast MRI. Furthermore, we tried to determine if there was any indication of reduced lymphatic function, in peripheral vessels, using NIRF imaging in Fontan patients compared to healthy individuals. Finally, the microvascular fluid filtration was examined by strain gauge plethysmography, and all our findings were compared with a healthy control group.
METHODS
The data, analytic methods, and study materials will be/have been made available to other researchers for purposes of reproducing the results or replicating the procedure.
Study Population
The inclusion criteria were patients with a Fontan circulation operated at Aarhus University Hospital (Denmark) between 1990 and 2010. Exclusion criteria included age <18 years, mental illness, and genetic syndromes. Fontan patients (n=10) accepting an invitation for investigation were compared with healthy age-and sex-matched control subjects (n=10) recruited via flyers. Patients and controls were included in random order during the study period.
Study Design
Each participant underwent NIRF imaging of the lymphatic vessels and plethysmography of the lower limbs followed by noncontrast MRI of the lymphatic vessels from the foot to the neck. To eliminate any circadian influence, the tests were conducted before midday, and the subjects were instructed to refrain from heavy physical exercise and alcoholic beverages 12 hours before the testing. Furthermore, they were disallowed intake of xanthine-containing beverages or foodstuffs during the tests.
Throughout NIRF imaging and plethysmography, the study subjects were placed in the supine position in a standard hospital bed in a completely dark room without sunlight. The room temperature was maintained at 23 to 27°C. During the protocol, time and temperature were noted before each study sequence. Next, a 45-minute MRI protocol was performed, and the entire protocol had a duration of ≈4 hours.
Study Protocol

NIRF Imaging of Lymphatic Vessels in Humans
Lymphatic vessels in the right lower leg and foot were investigated using NIRF imaging as described previously. 13, 14 In brief,
CLINICAL PERSPECTIVE
The Fontan patients often develop what seems to be a syndrome of chronic lymphatic hypertension, which is the cause of multiorgan dysfunction and ultimate early death. This is the first study to look at the functional capacity of the human lymphatic system in Fontan-operated patients using near-infrared fluorescence imaging of cutaneous lymphatic vessels. The increased central venous pressure necessary to drive the Fontan circulation is a challenge for the lymphatic circulation. First, the increased central venous pressure results in increased fluid filtration, and second, the lymphatic vasculature has to overcome the increased pressure gradient where the lymphatic system enters the vascular system in the central veins. In the current study, these well-functioning Fontan patients' engorged lymphatic vessels generate lower contractile force but seem to overcome the fluid challenge by contracting at a higher frequency. The increased chronotropic potential displayed in the lymphatic vasculature may allow for future pharmacological intervention to delay or cure the multiorgan dysfunction seen in the failing Fontan patient.
after 15 minutes of acclimatizing to the supine position and room temperature, the fluorescent dye indocyanine green (ICG; Nomeco, Denmark) was injected intradermally on 3 locations on the right foot; distally in the first and fourth interdigital spaces, and behind the medial malleolus. Before injection, ICG was dissolved in sterile water and further diluted with isotonic saline to a final concentration of 0.3 gL −1 , before injecting 0.1 mL (30 μg ICG) of the solution intradermally with 31G needles (Wiotech, Denmark). After the intradermal injections, the dye was taken up by the superficial lymphatic vessels and will, under normal conditions, remain in the vessels after binding to serum proteins. 19 A custom-designed 785 nm 450 mW laser (PowerTechnology), with a 780±28-nm band-pass filter, was used as light source for excitation of ICG, and a lens was mounted to spread the light. Images were obtained with an electron-multiplier charge-coupled device camera (C9100-13; Hamamatsu, Japan), with a Navitar lens (25 mm f0.95) with two 835±15 nm (>Optical Density 5) band-pass filters mounted in front and behind. Image capture was set to 3.33 s −1 , and gain was set to 1200. The images collected were displayed in real time on a monitor and were saved on an external hard drive for later analysis ( Figure 1A ).
All 4 image sequences started with the subjects lying supine and still for 3 minutes before filming commenced. The first sequence was acquired during injection (Movie I in the Data Supplement) of ICG followed by a 20-minute resting period to allow accumulation of ICG in the lymphatic vessels.
Next, a 6-minute standard NIRF acquisition sequence was obtained of the lower leg (Movie II in the Data Supplement) with the subject supine and lying still (to eliminate any extrinsic influence on the lymphatic function). Subsequently, assessment of refill time and pumping pressure were completed in 2 separate image sequences. More detailed description of the different sequences follows in the next section.
Quantification of Lymphatic Function
Lymphatic function was assessed by quantifying contraction frequency, velocity, refill time, and pumping pressure. Image sequence analysis was completed in ImageJ 1.47 (National Institutes of Health) and using a custom-written LabVIEW 12.0 program (National Instruments). Regions of interest (ROIs) were plotted in each measureable vessel and in each sequence, and intensity was measured throughout the course of the sequence. Analyses were conducted blinded and performed twice by the same observer on different days with an interval of 1 month. Contraction frequencies, velocities, and refill times were derived from the average of all visible and measurable vessels (Figure 2 ).
Contraction Frequency
A contraction was defined as an increase in intensity or visual confirmation that a packet of lymph passed through an ROI. Both the raw signal in the ROI and the differentiated plot (signal/time) were displayed in the LabVIEW program. In the raw signal plot, contractions were seen as spikes, whereas in the differentiated plot, contractions were seen as a positive spike that continued into a negative deflection before returning to baseline ( Figure 2D ). The number of negative deflections and visual packets were counted over the acquired 6-minute baseline sequence, and the frequency was calculated.
Velocity
The velocity of the movement of a packet of lymph was estimated by placing 2 ROIs 5 to 10 cm apart on each vessel and measuring time difference between the lymph packet occurring in 2 different ROIs. Velocity was determined only from straight vessel segments without bifurcations. Furthermore, velocity was only measured in packets that moved continuously, without pause, through both ROIs (Figure 2A and 2B) . A calibration scale was inserted before initiation of each image sequence to determine the distance between the ROIs. Velocity was determined over the acquired 6-minute baseline sequence, and the frequency was calculated.
Refill Time
Refill time was defined as the time taken after complete manual emptying of lymph in the whole region investigated for the fastest vessel to refill with ICG fluorescent lymph. A tourniquet was placed just above the malleolus to block lymph flow, and the lymphatic vessels in the calf were emptied by manual massage. Immediately after emptying, the tourniquet was detached and the time spent refilling 5 cm of vessel was measured. Three consecutive measurements were acquired, and an average value of these was calculated.
Pumping Pressure
We define pumping pressure as the maximal occlusion pressure where lymphatic vessels can still maintain lymph transport. Pumping pressure was determined by occlusion of lymphatic flow by a Hokanson sphygmomanometer cuff (Marcom Medical, Denmark) after emptying the vessels of lymph fluid manually as described previously under the section Refill Time. The sphygmomanometer cuff was placed proximally to a tourniquet, preventing any lymph flow and inflated to 70 mm Hg (Hokanson E20 Rapid cuff inflator, Hokanson AG101 air source, SC10 cuff; Marcom Medical). The tourniquet was removed, and the pressure in the cuff was reduced with 5 mm Hg each fifth minute. The highest cuff pressure at which the fluorescent dye passes the inflatable cuff was recorded as the pumping pressure ( Figure 1B and 1C).
Lymphatic Anatomy Using Noncontrast MRI
The lymphatic anatomy of the neck, entire chest, abdomen, and leg (as caudal as feasible based on coil position) was imaged and investigated with a 3-T MRI system (Siemens Skyra; Siemens Medical, Germany). The patient was positioned with the head first and supine, and dedicated multiarray radiofrequency coils were positioned on the chest/torso/ abdomen, pelvis, and upper and lower legs, together with a spine coil integrated in the sliding bed. First, a whole-body survey was acquired from neck to feet using standard gradient-echo protocols, allowing a fast anatomic portrait of the body. Second, the lymphatic system was imaged using the following procedure, from neck to feet, coronal slides were acquired with a respiratory-gated (navigator) 3-dimensional fast T2-weighted spin-echo sequence and the following parameters: matrix, 448×448; voxel size, 0.9×0.9×0.8 mm3 field-of-view varied on body size and anatomic region, 100 to 400 cm2, repetition time, 2830 ms; echo time, 649 ms; flip angle, 125°; number of repetitions, 1; no fat saturation; and no prepulse. This sequence was repeated sequentially for whole-body coverage.
Quantification of Lymphatic Anatomy
Thoracic duct: Tortuosity (Relative Length)
MRI images were analyzed, segmented, and illustrated using the LabelField module in the 3-dimensional software Amira 6 (Field Electron and Ion Company, Visualization Sciences Group, France) and ImageJ 1.50e (Wayne Rasband). Two observers anatomically defined the thoracic duct (TD) from the evaluated MRI images. In the event of disagreement, a third observer was available, but we did not experience a need for this in the current study. All intact parts of the TD above the diaphragm were recognized and manually fitted with a line to measure the actual length of the TD. Then, the length (straight length) of the thoracic cavity covered by the TD was measured. The actual length of TD divided by the straight length of the TD provided the relative length of TD: the relative length thus indicates the degree of TD tortuosity. The relative length of a completely straight TD with no tortuosity will be close to 1.00 because the actual length of the TD and the straight length of the thoracic cavity covered by the TD will be almost the same. However, if the TD is more tortuous and thus elongated, the relative length of TD will be >1.00. By determining the relative length, we can eliminate the differences in TD length that could be because of normal variation, height, and MRI acquisition quality.
TD: Average Diameter
Three-dimensional software Amira 6 was used to estimate the segmented TD volume in mm 3 . The estimated volume divided with the actual length of the TD gives the average area (A) in mm 2 . Average diameter was calculated by: 2×(√A/π). Only TD parts above the diaphragm were included in the calculations.
Capillary Filtration Rate
Capillary filtration rate in the right calf was measured using a strain gauge plethysmograph setup (Hokanson EC6 and E20; Marcom Medical) connected to a personal computer using an analog-to-digital converter (ADInstruments, United Kingdom) and analyzed using LabChart 7 software. A 5-step, 20-minute venous congestion protocol was used to measure capillary filtration. The cuff was rapidly inflated to and held at 20 mm Hg, and the pressure was increased every 3 minutes with 10 mm Hg until 70 mm Hg was reached. The calf volume was recorded continuously by the strain gauge, placed distal to the cuff, corresponding to the place with the largest circumference. Initially, an acute increase in venous pressure results in a fast, nonlinear increase in calf volume because of venous distension. The increased venous pressure results in increased capillary hydrostatic pressure, which augments capillary filtration rates. The increase in interstitial fluid volume (edema formation) results in a linear increase in calf volume. The capillary filtration rate (µL×100 mL
) was measured as the slope of the time-volume change (%) curve at steady state at the end of each pressure phase and was measured at 20, 30, 40, 50, and 60 mm Hg. [15] [16] [17] [18] Strain gauge plethysmography force data (mN) were analyzed using LabChart 7 software (ADInstruments).
Lower Leg Volume Estimation
Lower leg volume was estimated by water displacement. A container was filled with 25 cm of 30°C water before the A, Sketch of near-infrared fluorescence imaging setup. After uptake of indocyanine green by the superficial lymphatic vessels in the lower leg, a laser is used to excite the fluorescence dye. A camera is then used to collect the emission wavelengths, which are displayed on connected monitor in real time. B, Illustration of cuff placement on the lower leg for determination of pumping pressure. C, Examples of static images from near-infrared fluorescence imaging during lymphatic pumping pressure measurement; (left) the cuff is inflated to 70 mm Hg, and the lymph is accumulated at the distal border of the cuff in all 4 vessels present (green arrow) while proximal for the cuff the lymphatic vessels are empty; (right) the cuff is slowly deflated, and at 50 mm Hg, lymph passes under the cuff in one of the vessels (red arrow), representing lymphatic pumping pressure.
participant submerged the right foot completely. The position of the lower leg was kept constant until the displaced water was fully emptied from the container. The displaced water, corresponding to the volume of the lower leg, was collected and weighed. The measurement was repeated 3×, and an average was determined.
Ethical Approval
The clinical trial lymphatic function in patients with a Fontan circulation was approved by the Central Denmark Region Committees on Health Research Ethics (1-10-72-341-13) and the Danish Data Protection Agency. The study is registered in https://www.clinicaltrials.gov (NCT03379805). Written informed consent was acquired from all study participants. The entire study was completed following the ethical principles for medical research involving human subjects and tissue as directed by the Helsinki declaration.
Statistics
Microsoft Excel 2011 (14.5.2) was used for data storage, and all statistical analyses and graphical presentation of the results were conducted using GraphPad Prism 6 and Stata/SE 15.1. All data were tested for normality and presented as mean±SD and for significance with the unpaired Student t test (data with 2 samples) and 2-way ANOVA. Significance level was set to 0.05 in all tests. Based on a mean pumping pressure found in our NIRF imaging validation study 13 of 56.5 mm Hg and an SD of 9, 10 patients and 10 controls were required to find a 20% difference in pumping pressure with a power of 80% and significance level set to P <0.05. Intraobserver agreements were tested using the intraclass correlation (ICC) coefficient calculated with a 2-way mixed model for absolute difference between 2 measurements. 20 The ICC coefficient was presented with 95% CIs. To evaluate interrater agreement for identifying Fontan patients apart from control subjects on thoracic noncontrast MRI, Cohen kappa coefficient (κ) was calculated.
RESULTS
Study Population
The Fontan patients included in the study had various primary congenital heart defects, but all ended up receiving a total cavopulmonary connection. At the time of examination, the patient group had an average time since total cavopulmonary connection of 15.6±3.6 years. The CVP pressure in the Fontan circulation was measured routinely at cardiac catheterization 6 months after completion of the total cavopulmonary connection in each patient and was on average 11.0±2.2 mm Hg. Cardiac catheterization was not performed routinely after this point of time in the included Fontan patients; so to keep uniformity in the results, only 6-month postoperative cardiac catheterization data are reported. All 10 Fontan patients were placed in New York Heart Association classification 1 and had a good systemic ventricular function in their latest echocardiography with a saturation ranging from 90% to 98%. One patient (subject G) showed a slight decrease in systemic ventricular function on echocardiography but had no symptoms or consequence due to the finding.
The blood pressure in the Fontan patients (123±11/79±8 mm Hg) was not different from the healthy controls (118±10/76±6 mm Hg). One of the patients had intermittent problems with facial and peripheral edema (subject B). He had unilateral edema in the left leg at the time of examination ( Figure I in the Data Supplement). An additional 2 patients (subjects G and I) experienced periodically from edema but were asymptomatic at the time of testing.
Except from the subject B (Figures I and II in the Data Supplement, detailed description of the patient in the Data Supplement), none of the patients received any kind of cardiovascular medication (ion channel blockers, ACE inhibitor, or angiotensin receptor blocker) or diuretics. However, 4 patients received anticoagulation treatment at the time of examination (subjects B, C, F, and H). None of the control subjects received any medication. The demographic and clinical characteristics of the Fontan patients and the healthy controls are described in Table 1 . None of the patients or subjects reported experiencing chronic venouse insufficiency, and clincally, no signs of chronic venouse insufficiency were observed during the testing. Cardioventricular MRI or echocardiography was not performed as part of this study.
NIRF Imaging
The average number of vessels analyzed per subject was 4.2±1.9 (n=20) and was not different between the 2 groups (P=0.5001).
Pumping pressure in the lower leg lymphatics was lower in patients with a Fontan circulation, 50.8±3.1 mm Hg, compared with healthy controls, 60.3±2.8 mm Hg (P=0.0341; Figure 3A) . Conversely, contraction frequency was higher in the Fontan group, 0.8±0.1 min −1 , compared with the controls, 0.5±0.1 min −1 (P=0.0432; Figure 3B ). There was a tendency to a faster refill time in the Fontan patients, 195±61 s, compared with the controls, 378±76 s (P=0.0782; Figure 3C ). The velocity by which the lymph was propelled forward after each contraction was not different between the Fontan patients (23±3 mm×s −1 ) and the healthy control group (19±2 mm×s −1 ; P=0.2676; 3 days). The continuous movement of lymph was measured over an average distance of 66±14 mm. NIRF imaging revealed normal vessels in the lower leg of the patient with unilateral edema/lymphedema in his left leg. However, above the knee and thigh, large contractile collecting lymphatic vessels were absent; instead, Data are presented as means±SD. BMI indicates body mass index; CHD, congenital heart defect; DILV, double-inlet left ventricle; DORV, double-outlet right ventricle; F, female; HLHS, hypoplastic left heart syndrome; ID, identification; M, male; TA, tricuspid atresia; TCPC, total cavopulmonary connection; and TGA, transposition of the great arteries.
*Subject B had edema in the left leg at the time of investigation. dermal rerouting, also called "dermal backflow," was present. Dermal backflow represents extravascular lymph leakage through dermal lymphatic collaterals, which is the end result of lymphatic obstruction. 21 Furthermore, we saw abnormal lymphatic collateralization of contractile collecting lymphatics in the groin area ( Figure IA through ID in the Data Supplement). NIRF imaging of his nonedematous right leg showed morphological normal vessels in his lower and upper leg ( Figure I in the Data Supplement, detailed description of the patient in the Data Supplement).
Intraobserver Reliability
We found an intraobserver, ICC coefficient of 0.98 in pumping pressure estimation, and for contraction frequency, ICC coefficient was of 0.95. The calculations for velocity measurement had an ICC coefficient of 0.79. The calculations for these 3 parameters consisted of 20 pairs of observations.
Magnetic Resonance Imaging
Eight of 10 patients and 10 controls completed the MRI procedure. The findings from MRI of the thoracic cavity and abdomen are summarized in Table 2 . General characteristics of the TD from the control subjects were that the TDs were lean, straight, and with no lymphangiectasia ( Figure 4K through 4T). Subject P had a dilatation at the termination of the TD into the subclavian vein in the left neck area ( Figure 4P ), and subject M had a midthoracic dilatation of the TD. The characteristics of the TD in the Fontan subjects seemed to be more tortuous compared with controls, and several of them presented with different types of lymphatic malformations ( Figure 5A through 5J) . Tortuous and dilated TDs were found in subjects B, F, and J. In the thoracic and abdominal cavity, the Fontan patients had generally more fluid accumulated around the liver (tissue edema), and some patients had abnormal lymphatic collaterals in the shoulder, chest, and abdominal wall ( Figure IIIB , IIIC, IIIH, and IIIJ in the Data Supplement). Two control subjects presented some lymphatic vessels in the chest wall ( Figure IVK and IVL in the Data Supplement) but not to the same extent as found in the Fontan patients. The lymphatic vessels in the lower extremities of the Fontan patients ( Figure 6 ) and healthy controls ( Figure 7) were imaged. Only the Fontan patient B revealed abnormal 
Tortuosity (Relative Length) of the TD
The relative length of the TD in the Fontan patients, 1.12±0.09, was higher compared with the healthy controls, 1.05±0.04, suggesting a more tortuous and thereby an elongated TD (P=0.0409; Table 2 ).
Average Diameter of the TD
The average diameter of the TD in the Fontan patients was 2.7±1.1 mm and comparable to the healthy controls, 2.7±1.1 mm (P=0.9931; Table 2 ).
Interrater Agreement of Noncontrast MRI
Ten medical researchers (medical doctors and medical students) with no prior experience with lymphatic MRI were instructed to identify Fontan patients apart from control subjects by blinded examination of the noncontrast T2-weighted MRI images of the thorax from Figures III and IV in the Data Supplement. The 10 raters evaluated the 18 images on the basis of the following 3 characteristics for Fontan patients (based on the MRI study by Dori et al 8 ) : (1) ductus thoracicus is more torturous in Fontan patients, (2) the presence of lymphatic collaterals and lymphangiectasis (abnormal lymphatic vessels in the thorax and abdomen of Fontan patients), and (3) the presence of areas of high T2-signal in the liver, lungs, or abdomen consistent with tissue edema.
Cohen kappa coefficient for the 10 raters showed adequate interrater agreement with good (n=5; κ=0.67-0.78), moderate (n=4; κ=0.55), or fair (n=1; κ=0.325) values of Cohen kappa. The amount of agreement indicates that we can reject the hypothesis that they are making their determinations randomly.
Correlation Between Morphology and Function
No correlation was found between TD tortuosity (relative length) and pumping pressure (P=0.2707) or contraction frequency (P=0.4987) for all study subjects (n=18). Thoracic duct was depicted (green) for the control group. Control subjects M and P revealed some abnormal lymphangiectasia of the thoracic duct; otherwise, the thoracic duct of control subjects was found to be straight and lean.
Furthermore, no correlation was found between average diameter of TD and pumping pressure (P=0.4389) and contraction frequency (n=18; 30.1272). There were also no correlations for all parameters when looking at the 2 groups individually.
Capillary Filtration Rate
All participants completed the strain gauge plethysmography of the right calf; however, the results from 6 subjects (4 patients and 2 controls) were excluded because of measurement errors and artifacts hampering the analysis. The volume of the right lower leg was not significantly different (P=0.8742) between the 2 groups, and the pooled measured mean lower leg volume was 1.54±0.12 L.
The mean capillary filtration rate was not different between Fontan patients (n=6) and healthy controls (n=8) at any of the 6 pressure steps between 20 and 70 mm Hg (2-way ANOVA; post test Bonferroni; P=0.6942; Figure 8 ).
DISCUSSION
In this study, we demonstrated quantifiable evidence of structural and functional changes to the lymphatic system in Fontan patients. The collecting lymphatic vessels in the lower leg of the Fontan patients were found to have a reduced pumping capacity, characterized by a 17% lower maximal pumping pressure compared with the healthy volunteers, whereas the contraction frequency was increased by 62% in the Fontan patients perhaps as a form of functional compensation. MRI showed collateralization and abnormalities of the lymphatic vessels in the chest and a tortuous TD in the Fontan patients. However, at the microvascular level, there was no measurable difference in microvascular permeability between the groups. patients (A-J) . Thoracic duct was depicted (green) for the Fontan patients. MRI of patients A and D was not performed. Most of the Fontan patients showed a tortuous thoracic duct (B, C, F, H, and J), and some of the ducts were found to have diffuse lymphatic fluid and small collaterals around them (C, E, G, and H).
Functional Data
The Fontan circulation generally leads to an elevated CVP, resulting in an increased capillary filtration according to the Starling forces. The lymphatic vasculature is a linear vasculature divided into small segments (mm/ cm in length), termed lymphangions, which are separated by unidirectional valves and terminates in the great veins of the neck. The lymphatic circulation lacks a central pump to drive the transport of lymph. Instead, each lymphangion acts like a contractile unit and generates spontaneous contractions. Lymph transport is predominantly a result of these contractions and, like the heart, lymphatic flow is the result of contraction frequency×stroke volume. [22] [23] [24] [25] The Fontan circulation does thus challenge the lymphatic vasculature in 2 different ways, first by increasing the amount of fluid that the vessels must remove to maintain a normal tissue fluid balance and secondly by increasing the afterload (CVP) of the vasculature as a whole. We have previously shown that, under normal circumstances, the lymphatic vessels in humans are capable of generating systolic pressures around 60 mm Hg both ex vivo in the TD and in vivo in the legs of healthy volunteers. 13, 23 Reduced maximal pumping pressure has been described in several studies of patients with lymphedema. 26, 27 Interestingly, we also observed this phenomenon in Fontan patients, in which 9 of 10 were without clinical edema. A reduced maximal pumping pressure suggests diminished contractility. The mechanism by which this occurs is not completely understood, but both increased fluid load to the lymphatic vasculature and increased afterload has been suggested. Discriminating completely between these 2 mechanisms is complicated. Although simplified, each lymphangion acts as an independent contractile unit and as such is only influenced by the conditions of the adjacent lymphangion situated upstream and In the lower extremities, we generally observed that the patients had comparable numbers and localization of lymphatic vessels as the healthy controls except from the Fontan patient with unilateral edema (subject B).
downstream, respectively. The afterload of 1 lymphangion is, therefore, the preload of the next lymphangion downstream and vice versa. Acute experiments of isolated single lymphangions have shown that an increase in afterload results in increased contractility. 28 Acute experiments of an isolated increase in afterload of a chain of several lymphangions have shown that the lymphangions upstream pump better than the ones downstream. 29 Thus, with increased CVP, it is possible that lymphangions that are far upstream could be protected from the elevated afterload. However, these observations come from animal experiments of acute alterations to afterload and do not provide insight into the changes that occur with chronic increased afterload and human lymphatic vasculature. This was addressed in the study by Modi et al 30 that showed reduced pumping pressure in lymphedematous arms from patients with breast cancer. It, therefore, seems, similarly to the heart, that increased resistance or afterload can be compensated for initially but can lead to long-term failure.
The ability to generate force is dependent on stretch, and this applies to all muscles. In the heart as a whole, Frank and Starling described this functional correlation in the late 19th century and early 20th century. We have previously characterized the relationship between stretch and force production of human lymphatic vessels ex vivo 23 and have found that the vessels operate well under a wide range of diameters. However, if the vessels are overstretched, then the force production will decline. It is, therefore, feasible that lymphatic vessels in the lower limb dilated beyond the optimal state for contraction result in lower pumping pressures.
The increased lymphatic contraction frequency is interesting. Three different mechanisms could be involved: (1) a compensatory mechanism to reduced contractile function (lymph output=contraction frequency×stroke volume), (2) increased fluid load to the lymphatic vessels, and (3) stimulation of adrenergic receptors. Despite normal microvascular permeability in Fontan patients (as shown by the plethysmography data), the capillary filtration of fluid is increased because of elevated CVP, and the lymphatic vessels need to remove more fluid to maintain normal tissue fluid balance. One way of doing this would be to increase contraction frequency. Regarding the last proposed mechanism, it has been shown recently that Fontan patients have 20% increased level of circulating norepinephrine and increased sympathetic tone in the leg. 31 We have shown ex vivo that α-adrenergic stimulation with norepinephrine and stimulation of the adrenergic nerves increase contraction frequency in human lymphatic vessels. 14, 22, 23 The increased lymphatic contraction frequency in our study could, therefore, also be secondary to increased levels of circulating catecholamines or local sympathetic tone.
Morphological Data
The TD was elongated by 10%. The average diameter was no different from healthy subjects and corresponded with previous MRI findings in Fontan patients with no severe complications (2.3 mm; range, 1.3-5.3 mm; n=21) and subjects without a Fontan circulation (2.3 mm; range, 1.7-2.6 mm; n=10). 8 Dori et al disclosed a significant difference between the Fontan patient without severe complications and a group of Fontan patients, with more severe morbidities such as proteinlosing enteropathy or plastic bronchitis (3.9 mm; range, 3-7.2 mm; n=6).
We have previously shown that the lymphatic smooth muscle cells in the TD are not organized in a pure circumferential direction but more like a loose basket weave. 24 Therefore, it is possible that the 10% elongation of the TD in the Fontan patients could be deleterious for pumping although there was no difference in diameter. 
Limitations
At present, the ICG-based NIRF technique used here is limited to visualization within a depth of a few centimeters below the skin. Regional variation in the pumping activity of lymphatic vessels has been described. 32 Despite our inability to describe the function of all the various lymphatic vessels that could be dysfunctional in Fontan patients, we believe our findings do contribute to furthering our understanding of the Fontan circulation. It has previously been demonstrated in patients with unilateral edema that the contralateral limb also showed evidence of lymphatic dysfunction. 33 It is, therefore, reasonable to surmise that useful information concerning lymphatic function in general can be obtained by examining areas of the body that are not necessarily the most clinically affected.
The main limitation of noncontrast MRI is that it does not provide any information about lymphatic function and flow patterns. Furthermore, there can be many artifacts because of respiratory and heart movements and other nonlymphatic fluid-containing structures such as the stomach, cerebrospinal fluid, and effusions. Finally, smaller lymphatic vessels will not be apparent because of the small volume of lymph in these vessels-a limitation that could be overcome by contrast. Dynamic contrast MR lymphangiography has been introduced to overcome some of the limitations of the original noncontrast MRI protocol. This technique allows for a better temporal and spatial resolution, in which both morphology and dynamic flow can be assessed. Unfortunately, dynamic contrast MR lymphangiography is more invasive. 11, 34, 35 Plethysmography is widely used for microvascular assessment. 15, 16 Although, technical and biological artifacts are cause of significant exclusion of data. 16 We had to discard several measurements because of artifacts such as movements of other extremities or head, myoclonic jerks, and spontaneous change in baseline. In the majority of discarded measurements, only single steps from the entire protocol were compromised; however, we chose to remove the entire test to maintain a nonbiased analysis. Greater care must be taken during the test in future studies to ensure high-quality data acquisition, and prolonging the protocol time to achieve baseline steady state seems to be necessary.
Our study comprised a small group (n=10) of Fontan patients, and all, with the exception of subject B, were without any severe complications. Inclusion of more patients and less optimal functioning individuals could reveal further differences and provide additional insights into the role of the lymphatics in these patients.
Clinical Importance
It has become increasingly evident that an impaired lymphatic circulation could partially explain the deterioration of the Fontan patients' general condition. 8, 11, 36 In the healthy human body, ≈8 liters of interstitial fluid is filtered from the capillaries every day, 37 but in the Fontan patients, probably even more because of the elevated CVP. The only possible route for the fluid to return to the blood circulation is via the lymphatic vessels. However, the lymphatic vasculature is challenged in the Fontan circulation by the increased CVP, resulting in an increased fluid filtration into the interstitial space and an increased pressure gradient that the lymphatic system must overcome to return the fluid to the blood circulation. The lymphatic vasculature is a highly plastic system, and this is apparent in Fontan patients where some develop tortuous lymphatic vessels and abnormal collaterals as demonstrated on MRI in our study and by others. [8] [9] [10] TD embolization, pioneered by Dori et al, 35 has resulted in new ways to alleviate thoracic and abdominal complications of the Fontan complications. Pharmacological treatments that can be used systemically and target the underlying problems would represent a major breakthrough in the management of the Fontan patients. This requires both a further understanding of the pathophysiology and tools to investigate the effects of the treatments. We believe the techniques used in this study can be used for both of these purposes and that the current study adds a piece to the puzzle of understanding the complex Fontan circulation.
Conclusions
In this study of Fontan patients, we are the first to demonstrate diminished lymphatic pumping. Our results support the growing belief that the lymphatic vasculature is challenged in the Fontan circulation and indicate further functional and morphological studies are needed to elucidate the mechanism by which the lymphatic vasculature is part of the pathogenesis for complications in Fontan patients.
ARTICLE INFORMATION
